RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
Status:
Completed
Trial end date:
2020-01-18
Target enrollment:
Participant gender:
Summary
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Trial to Evaluate the
Safety and Efficacy of ADX-102 1% Topical Dermal Cream in Subjects with Sjögren-Larsson
Syndrome (SLS).